ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)

Last updated: May 13, 2025
Sponsor: University of Washington
Overall Status: Active - Recruiting

Phase

N/A

Condition

Weight Loss

Obesity

Diabetes Prevention

Treatment

Behavioral Weight Loss Program

Clinical Study ID

NCT06174389
STUDY00017667
R01DK134417
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Behavioral weight loss programs for obesity can result in weight loss and health benefits. However, behavioral weight loss often stops despite efforts to continue losing weight, this can be called an involuntarily weight loss plateau. This study investigates changes in metabolism and/or the brain that contribute to the occurrence of an involuntary weight loss plateau.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • BMI 30.0 - 50.0 kg/m2

  • Able to attend study intervention classes and study visits/assessments

  • Independently living with access to food preparation facilities

Exclusion

Exclusion Criteria:

  • Current smoker or regular use of nicotine containing products and/or cannabis

  • Heavy alcohol use (≥2 drinks/d for females, ≥3 drinks/d for males) or drug use

  • Known cognitive impairments or h/o stroke

  • Type 2 diabetes (known diagnosis or by screening A1c (≥6.5%))

  • Medical conditions (chronic diseases, cancer, MS) or labs limiting ability toparticipate

  • Females: currently pregnant (or 6-months postpartum of full-term pregnancy) and/orcurrent breastfeeding

  • Use of medications with significant effects on appetite (e.g., weight lossmedications, atypical antipsychotics, stimulants) and/or chronic use ofanticoagulants

  • History of bariatric surgery

  • History of eating disorder

  • Current participation in a formal weight loss program

  • Prior or current participation in a research study involving weight loss

  • Weight-reduced by >10% within past year

  • Weight > 330 pounds (MRI limit)

  • Allergy or intolerance to or unwillingness to consume study foods provided at visit

  • MRI contraindication (e.g., implanted metal, claustrophobia)

  • Do not have a phone compatible with activity tracker or access to videoconferencingplatform that will be used for the dietary intervention or other appropriatetechnology needed to complete study procedures

  • Any condition(s) found by the study team and confirmed with the PI(s) that make itunsafe to participate

Study Design

Total Participants: 90
Treatment Group(s): 1
Primary Treatment: Behavioral Weight Loss Program
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
July 31, 2027

Study Description

Participants will be asked to enroll for 18-months. Each participant will complete 3 in-person study visits, then participate an a 6-month weight loss program delivered remotely. Some participants may be invited to complete 3 additional in-person visits. Study Visit activities include questionnaires, blood draws, brain MRIs, body measurement and dual energy x-ray absorptiometry (DXA) scan for body composition measurement, a breathing test, and biopsies of muscle and fat tissue. Each participant will be provided a fitness tracker and body weight scale to use throughout the study.

Connect with a study center

  • Fred Hutch Cancer Center

    Seattle, Washington 98109
    United States

    Site Not Available

  • University of Washington - South Lake Union

    Seattle, Washington 98109
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.